Commemorative Series No. 2 · The Drug Money
OUTSPENTNo. 27/54
Kent
Conrad
U.S. Senate · D-ND
Taken from pharma & insurers
$31,250
H.R.1 · Medicare drug-price ban · 2003tap to flip ⤺
WHO THEY WORK FORNo. 27/54
Pharma & Health$22,250
Insurers & HMOs$9,000
Banned Medicare from negotiating drug prices for 19 years. Once it could (2024), prices fell 38–79%. · 108-1-459OUTSPENT
Card 27 of 54 · tap the card to see who they work for
Beyond the check
The check is only the part you can see.
They took
$31,250
The industry spent on the bill
$116M
on drug-industry lobbying in 2003, about ten lobbyists for every senator
Then, after office
Joined the board of the insurer Genworth weeks after leaving the Senate.
Source: Bloomberg, 2013
The industry figure is lobbying spent on the bill, not a payment to this senator. Source: Public Citizen (2004); Center for Public Integrity. Everything here is documented public record; nothing alleges an illegal act.
Don't recognize a logo? Here's the key.
Pharma & Health$22,250
Johnson & Johnson$16,750
Merck$2,000
Amgen$1,000
Bristol Myers Squibb$1,000
PhRMA$1,000
Pfizer$500
Insurers & HMOs$9,000
UnitedHealth$3,000
Aetna$3,000
AHIP$3,000